Venture-Backed Startups

Biotheryx discovers and develops targeted protein degrader drugs designed to treat cancer and inflammatory diseases. The company uses its proprietary PRODEGY platform to create molecular glues and bifunctional degraders, with lead programs in clinical trials for oncology indications including breast cancer and hematologic malignancies.

2 investors

0 investors

Biotia develops diagnostic tests and software for infectious disease detection using metagenomic sequencing and AI. The company serves patients, healthcare providers, and hospitals seeking pathogen identification and infection control intelligence.

7 investors

Biotic Labs develops bio-based, biodegradable polymers made from feedstocks such as sea algae and agricultural waste as a direct replacement for conventional plastics. The company serves manufacturers seeking plastic alternatives that integrate into existing production lines while supporting circular economy principles.

3 investors

0 investors

BioticsAI develops AI-powered computer vision solutions for fetal anatomy screening and maternal ultrasound diagnostics. The company serves healthcare providers and maternal-fetal medicine specialists seeking to standardize and improve the accuracy of prenatal ultrasound assessments.

1 investor

Biotitan develops nanotechnology-based surface treatments with bactericidal and virucidal properties for various environments. The company offers tailored turnkey solutions, training, and custom application services.

1 investor

Biotix develops natural, sustainable skincare ingredients derived from skin microbiome microbes, using an AI platform alongside biology experiments to identify and test ingredients for efficacy and safety. Its lead ingredient, Probix, is a microbial fermentation-derived compound intended to reinforce natural skin functions and protect against environmental irritants.

1 investor

Biotoken connects regenerative agricultural producers with organizations seeking to offset carbon emissions through a decentralized marketplace. The platform tokenizes carbon capture from farms into tradeable digital assets (TCOE), enabling transparent verification and direct transactions between carbon generators and compensators.

1 investor

0 investors

The page presents cardiac interventional and electrophysiology products—including transseptal sheaths and needles, occlusion balloons, guiding sheaths, guidewires, hemostasis valves, and compression devices—branded under Merit Medical for use in procedures such as lead extraction, cardiac resynchronization therapy, and CRM implantations. The products are aimed at electrophysiologists and cardiac care clinicians.

1 investor

1 investor

Biotricity develops FDA-cleared wearable cardiac and remote patient monitoring devices that continuously capture ECG and vital-sign data for patients and deliver reports to physicians. Its products include the Bioflux/Biocore rhythm monitors and Biokit for clinics, plus consumer-facing Bioheart and HeartSecure heart-monitoring offerings.

0 investors

Biotronics3D provides a cloud-based, zero-footprint medical imaging platform with RIS and PACS functionality, teleradiology modules, and AI-assisted diagnostic tools for hospitals, clinics, imaging centers, and teleradiology providers. The platform supports image routing, reporting, and workflow management, and is used across more than 400 sites in Europe.

1 investor

Biotts develops transdermal drug delivery products using its proprietary MTC-Y carrier system, a semisolid emulsion that transports both lipophilic and hydrophilic molecules up to 6,000 Da (including peptides and proteins) through the skin. The company creates its own transdermal drug products and licenses its technology and development expertise to the pharmaceutical industry.

1 investor

0 investors

BioVana operates a secure, federated network (the BioVana Index) that makes African biobank data discoverable to global researchers without moving samples, and offers ISO 20387-compliant sample-tracking software (Sampletrack). It provides access to African biospecimens and research-ready datasets for precision cohort discovery in the biotech and health research market.

1 investor

1 investor

Bioventus develops orthobiologics and pain treatment products for orthopedic care, offering therapies such as the StimRouter neurostimulation device for chronic peripheral nerve pain. Its portfolio serves patients, physicians, and payers in the medical device and healing space.

3 investors

1 investor

BioVeritas has developed a proprietary process that converts biomass—including wastes, residues, and purpose-grown crops—into a drop-in feedstock for existing refining and production capacity. The company initially targets sustainable aviation fuel (SAF) and renewable diesel (RD) via integration with HEFA production, with plans to extend the platform to other low-carbon fuels, chemicals, and products.

1 investor

Bioverse maps forest cover and species prevalence using satellite, drone, and AI/machine learning technologies to improve non-timber forest product harvesting, verify carbon and biodiversity credits, and support forest regeneration. It serves nature-based solution project developers and the cosmetics, food, and pharmaceutical industries across the Amazon Basin and other tropical biomes.

1 investor

BioVersys is a Swiss pharmaceutical company developing small-molecule drugs with novel modes of action to treat drug-resistant bacterial infections, addressing antimicrobial resistance (AMR). Its pipeline targets serious hospital infections such as A. baumannii, S. aureus, and NTM infections.

2 investors

0 investors